MALAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: To conclude, MALAT1 can promote the survival and imatinib resistance of CML cells by sponging miR-328 activity, providing an insight regarding the crucial function of MALAT1 as a miRNA sponge in CML [11].